HomeCompareCAH vs HII

CAH vs HII: Dividend Comparison 2026

CAH yields 0.99% · HII yields 1.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HII wins by $8.9K in total portfolio value
10 years
CAH
CAH
● Live price
0.99%
Share price
$206.31
Annual div
$2.04
5Y div CAGR
5.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.6K
Annual income
$185.04
Full CAH calculator →
HII
HII
● Live price
1.48%
Share price
$369.08
Annual div
$5.46
5Y div CAGR
27.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.4K
Annual income
$2,464.27
Full HII calculator →

Portfolio growth — CAH vs HII

📍 HII pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCAHHII
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CAH + HII cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CAH pays
HII pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CAH
Annual income on $10K today (after 15% tax)
$83.95/yr
After 10yr DRIP, annual income (after tax)
$157.28/yr
HII
Annual income on $10K today (after 15% tax)
$125.75/yr
After 10yr DRIP, annual income (after tax)
$2,094.63/yr
At 15% tax rate, HII beats the other by $1,937.35/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CAH + HII for your $10,000?

CAH: 50%HII: 50%
100% HII50/50100% CAH
Portfolio after 10yr
$26.0K
Annual income
$1,324.66/yr
Blended yield
5.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CAH right now

CAH
Analyst Ratings
18
Buy
15
Hold
Consensus: Buy
Price Target
$252.33
+22.3% upside vs current
Range: $220.00 — $275.00
Altman Z
4.8
Piotroski
5/9
HII
Analyst Ratings
12
Buy
14
Hold
1
Sell
Consensus: Hold
Price Target
$368.00
-0.3% upside vs current
Range: $264.00 — $421.00
Altman Z
3.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CAH buys
0
HII buys
0
No recent congressional trades found for CAH or HII in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCAHHII
Forward yield0.99%1.48%
Annual dividend / share$2.04$5.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR5.6%27.9%
Portfolio after 10y$21.6K$30.4K
Annual income after 10y$185.04$2,464.27
Total dividends collected$1.4K$9.0K
Payment frequencyquarterlyquarterly
SectorHealthcareIndustrials
Analyst consensusBuyHold
Analyst price target$252.33$368.00

Year-by-year: CAH vs HII ($10,000, DRIP)

YearCAH PortfolioCAH Income/yrHII PortfolioHII Income/yrGap
1← crossover$10,804$104.30$10,889$189.21$85.00HII
2$11,672$111.21$11,898$246.28$226.00HII
3$12,607$118.57$13,052$321.65$445.00HII
4$13,616$126.40$14,388$421.78$772.00HII
5$14,704$134.73$15,951$555.75$1.2KHII
6$15,877$143.59$17,804$736.46$1.9KHII
7$17,142$153.02$20,032$982.58$2.9KHII
8$18,504$163.04$22,756$1,321.55$4.3KHII
9$19,973$173.70$26,144$1,794.47$6.2KHII
10$21,557$185.04$30,438$2,464.27$8.9KHII

CAH vs HII: Complete Analysis 2026

CAHHealthcare

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Full CAH Calculator →

HIIIndustrials

Huntington Ingalls Industries, Inc. engages in designing, building, overhauling, and repairing military ships in the United States. It operates through three segments: Ingalls Shipbuilding, Newport News Shipbuilding, and Technical Solutions. The company is involved in the design and construction of non-nuclear ships comprising amphibious assault ships; expeditionary warfare ships; surface combatants; and national security cutters for the U.S. Navy and U.S. Coast Guard. It also provides nuclear-powered ships, such as aircraft carriers and submarines, as well as refueling and overhaul, and inactivation services of ships. In addition, the company offers naval nuclear support services, including fleet services comprising design, construction, maintenance, and disposal activities for in-service the U.S. Navy nuclear ships; and maintenance services on nuclear reactor prototypes. Further, it provides life-cycle sustainment services to the U.S. Navy fleet and other maritime customers; high-end information technology and mission-based solutions for Department of Defense (DoD), intelligence, and federal civilian customers; nuclear management and operations and environmental management services for the Department of Energy, DoD, state and local governments, and private sector companies; defense and federal solutions; and unmanned systems. Huntington Ingalls Industries, Inc. was founded in 1886 and is headquartered in Newport News, Virginia.

Full HII Calculator →
📬

Get this CAH vs HII comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CAH vs SCHDCAH vs JEPICAH vs OCAH vs KOCAH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.